MAGNESIUM SULFATE INJECTION, BP 49.3%

baxter corporation🇨🇦 Health Canada

Approval Id: 16852970c03ef288
Drug Approval Canada Name: MAGNESIUM SULFATE INJECTION, BP 49.3%
Product Name: MAGNESIUM SULFATE INJECTION, BP 49.3%
Status: Marketed
Status Date: 2021-10-01
Original Market Date: 2021-10-01
Din: 02513161
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Ethical
Ahfs: 40:12.00
Atc Original: B05XA05 MAGNESIUM SULPHATE
Atc Name: b 05 xa 05
Aig Number: 0105356002
Company Name: baxter corporation
Company Address: 7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2

MAGNESIUM SULFATE

493 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

16852970c03ef288

Type

Standard